Preparation of microspheres by the solvent evaporation technique.

[1]  H. Alpár,et al.  PDLLA microspheres containing steroids: spray-drying, o/w and w/o/w emulsifications as preparation methods. , 1998, Journal of microencapsulation.

[2]  R. Mehta,et al.  Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide) , 1996 .

[3]  Eric Doelker,et al.  Influence of the preparation method on residual solvents in biodegradable microspheres , 1996 .

[4]  T. Uchida,et al.  Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. , 1996, Chemical & pharmaceutical bulletin.

[5]  R. Bodmeier,et al.  Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on W/O/W-multiple emulsions , 1995 .

[6]  K. Anderson,et al.  Kinetic and thermodynamic modeling of the formation of polymeric microspheres using solvent extraction/evaporation method , 1995 .

[7]  T. Uchida,et al.  Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin. , 1995, Chemical & pharmaceutical bulletin.

[8]  W. Koff,et al.  The preparation, characterization and pre-clinical evaluation of an orally administered HIV-I vaccine, consisting of a branched peptide immunogen entrapped in controlled release microparticles , 1995 .

[9]  Roland Bodmeier,et al.  The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method , 1995 .

[10]  Tae Gwan Park,et al.  Preparation of porous and nonporous biodegradable polymeric hollow microspheres , 1995 .

[11]  H. Sah,et al.  Continuous release of proteins from biodegradable microcapsules and in vivo evaluation of their potential as a vaccine adjuvant , 1995 .

[12]  Tae Gwan Park,et al.  Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres , 1995 .

[13]  P. Menei,et al.  Preparation and Characterization of 5‐Fluorouracil‐loaded Microparticles as Biodegradable Anticancer Drug Carriers , 1995, The Journal of pharmacy and pharmacology.

[14]  R. Jerome,et al.  Effect of the emulsion stability on the morphology and porosity of semicrystalline poly l-lactide microparticles prepared by w/o/w double emulsion-evaporation , 1994 .

[15]  D. Rahman,et al.  Controlled release microparticles for oral immunization , 1994 .

[16]  H. Sah,et al.  The influence of biodegradable microcapsule formulations on the controlled release of a protein , 1994 .

[17]  Rajendra S. Pradhan,et al.  Formulation and in vitro release study on poly (DL-lactide) microspheres containing hydrophilic compounds : glycine homopeptides , 1994 .

[18]  P. Sansdrap,et al.  Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres , 1993 .

[19]  J. Lalla,et al.  Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route. , 1993, Journal of microencapsulation.

[20]  C. Sturesson,et al.  Preparation of biodegradable poly(lactic-co-glycolic) acid microspheres and their in vitro release of timolol maleate , 1993 .

[21]  R. Verrijk,et al.  Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide. , 1992, Cancer research.

[22]  J. C. Price,et al.  Simple gas chromatographic headspace analysis of residual organic solvent in microspheres. , 1992, Journal of pharmaceutical sciences.

[23]  Robert E. Johnson,et al.  Stability of atriopeptin III in poly(d,l-lactide-co-glycolide) microspheres , 1991 .

[24]  Robert J. Linhardt,et al.  Influence of formulation methods on the in vitro controlled release of protein from poly (ester) microspheres , 1991 .

[25]  Sumie Yoshioka,et al.  Preparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate , 1991 .

[26]  R Langer,et al.  New methods of drug delivery. , 1990, Science.

[27]  R. Jalil,et al.  Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. , 1990, Journal of microencapsulation.

[28]  R. Jalil,et al.  Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics. , 1990, Journal of microencapsulation.

[29]  R. Bodmeier,et al.  The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems , 1989 .

[30]  J. Benoit,et al.  Biodegradable cisplatiim microspheres prepared by the solvent evaporation method: Morphology and release characteristics , 1988 .

[31]  R. Bodmeier,et al.  Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method , 1988 .

[32]  R. Bodmeier,et al.  Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres. , 1987, Journal of microencapsulation.

[33]  Alan Smith,et al.  Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration , 1986 .

[34]  C. Thies,et al.  The formation and characterization of hydrocortisone‐loaded poly((±)‐lactide) microspheres , 1986, The Journal of pharmacy and pharmacology.

[35]  D. Lewis,et al.  Clinical evaluation of injectable biodegradable contraceptive system. , 1981, American journal of obstetrics and gynecology.

[36]  R. Langer,et al.  Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.

[37]  T. Cicero,et al.  In vivo and in vitro evaluation of a microencapsulated narcotic antagonist. , 1976, Journal of pharmaceutical sciences.

[38]  S. Yolles,et al.  Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites. , 1975, Journal of pharmaceutical sciences.

[39]  B. Cobb,et al.  An Experimental Approach , 1957 .

[40]  J. Mcginity,et al.  Properties of multiphase microspheres of poly(dl-lactic acid) or poly(dl-lactic-co-glycolic acid) produced by mechanical agitation, sonication, or potentiometric dispersion. , 1996, Journal of microencapsulation.

[41]  B. Conway,et al.  Double emulsion microencapsulation of proteins as model antigens using polylactide polymers : effect of emulsifier on the microsphere characteristics and release kinetics , 1996 .

[42]  A. Delgado,et al.  Use of Surfactants in Polylactic Acid Protein Microspheres , 1995 .

[43]  B. Conti,et al.  Investigation on process parameters involved in polylactide-co-glycolide microspheres preparation , 1995 .

[44]  J. Mcginity,et al.  Properties of multiphase microspheres of poly(D,L-lactic-co-glycolic acid) prepared by a potentiometric dispersion technique. , 1995, Journal of microencapsulation.

[45]  T. Park,et al.  Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. , 1995, PDA journal of pharmaceutical science and technology.

[46]  N. Udupa,et al.  Implantable flurbiprofen for treating inflammation associated with arthritis , 1994 .

[47]  J. Mcginity,et al.  Influence of nonionic surfactants on the physical and chemical properties of a biodegradable psuedolatex , 1994 .

[48]  J. Herrmann,et al.  Microencapsulation of chlorpheniramine maleate, a drug with intermediate solubility properties, by a non-aqueous solvent evaporation technique , 1994 .

[49]  A. Almeida,et al.  Identification of some of the physico-chemical characteristics of microspheres which influence the induction of the immune response following mucosal delivery , 1994 .

[50]  H. Sah,et al.  Evaluation of a Microreservoir-Type Biodegradable Microcapsule for Controlled Release of Proteins , 1993 .

[51]  E. Goldberg,et al.  Development of a contraceptive peptide vaccine for use with PGAL microspheres , 1993 .

[52]  J. Mcginity,et al.  Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique. , 1992, Journal of microencapsulation.

[53]  J. Kost,et al.  Experimental approach to elucidate the mechanism of ultrasound-enhanced polymer erosion and release of incorporated substances , 1992 .

[54]  R. Jalil.  Biodegradable Poly(Lactic Acid) and Poly (Lactide-Co-Glycolide) Polymers in Sustained Drug Delivery , 1990 .

[55]  R. Bodmeier,et al.  Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies. , 1988, Journal of microencapsulation.

[56]  T. Tice,et al.  Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament , 1986 .

[57]  T. Kondo,et al.  Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effects of pH, ionic strength and buffer concentration. , 1986, Journal of microencapsulation.

[58]  J. C. Price,et al.  Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(d,l-lactide). , 1985, Journal of pharmaceutical sciences.

[59]  T. Tice,et al.  Poly(lactide-co-glycolide) microcapsules for controlled release of steroids. , 1985, Methods in enzymology.